Announcing the 2021 PATH Intl. Veterinarian of the Year  

The Professional Association of Therapeutic Horsemanship (PATH Intl.) takes great pride in the exceptional veterinarians who serve at PATH Intl. Member Centers and the quality of life for the equines that partner with humans in equine-assisted services (EAS). PATH Intl. is pleased to announce the 2021 PATH Intl. Veterinarian of the Year, sponsored by American Regent Animal Health, maker of Adequan® i.m. (polysulfated glycosaminoglycan). We thank American Regent Animal Health for the way they have supported our centers and the equines that are at the heart of EAS.

2021 PATH Intl. Veterinarian of the Year

Dr. Jesslyn Bryk-Lucy, Therapeutic Riding at Centenary – TRAC, (a PATH Intl. Premier Accredited Center in Hackettstown, NJ)

Veterinarians at PATH Intl. centers are a special breed. Take Dr. Bryk-Lucy for example. Sometimes a veterinarian cares as much for the people at a center as she does the equines. When Dr. Jesslyn Bryk-Lucy started at Therapeutic Riding at Centenary’s (TRAC) equine studies in Hackettstown, NJ, she brought with her a passion for working with horses but also for educating students. Her obvious dedication to the care of the center’s horses and the ability to make people feel part of the treatment team are outstanding, as is her classroom expertise as she introduces students to the mysteries of conformation, health, illness, unsoundness and maintaining fitness for equines.

Her actions, focus, sense of urgency, ability to know just what to do and calmness in these situations are impressive and demonstrate true expertise and leadership to all around her.

TRAC’s director said, “Dr. Bryk-Lucy has been an amazing partner and advocate in ensuring the health of TRAC’s small program herd, resulting in a team of happy, willing horses who are kept fit and healthy for our program participants.”

Thank you as always to American Regent Animal Health/maker of Adequan® for their continued support and sponsorship of this award that recognizes the best veterinarians in equine-assisted services.  

About PATH Intl.:
The Professional Association of Therapeutic Horsemanship International® (PATH Intl.®) was formed in 1969 to promote safety and optimal outcomes in equine-assisted services (EAS) for individuals with special needs. At nearly 750 member centers, more than 66,000 children and adults, including 6,200 veterans, may find improved health, wellness and a sense of pride, independence and fun through involvement with horses. Therapeutic horsemanship at member centers may include hippotherapy, equine-facilitated mental health, driving, interactive vaulting, trail riding, competition, groundwork and stable management. Through a wide variety of educational resources, the association helps individuals start and maintain successful EAS programs. There are nearly 62,500 volunteers, 5,011 instructors, 7,800 equines and thousands of contributors from all over the world helping people at PATH Intl. Member Centers.

About American Regent Animal Health:
American Regent Animal Health, a division of American Regent, Inc., is committed to advancing animal health with proven FDA-approved products like Adequan® (polysulfated glycosaminoglycan). The company’s portfolio is anchored by the only FDA-approved polysulfated glycosaminoglycan products for horses and dogs, which have been relied on for nearly three decades by veterinarians. American Regent, Inc., a Daiichi Sankyo Group Company, manufactures and distributes human and veterinary pharmaceutical products and is committed to providing the ever-changing U.S. healthcare marketplace with a growing and diversified American Regent portfolio. For more information on American Regent Animal Health, visit or call 800-458-0163.

For more information, contact:
Cher Smith, Communications Specialist
(800) 369-7433, ext. 123

Images available on request.


AHP has not verified the factual statements in any message and AHP assumes no responsibility for the contents of, or any damage resulting from, any communication in the Newsgroup. Publication in the Newsgroup is not an endorsement by the organization of any product, person, or policy.